Lomitapide Mesylate
甲磺酸洛美他派(Lomitapide Mesylate)
CAS: 202914-84-9
化学式: C40H41F6N3O5S
| 中文名 | 甲磺酸洛美他派 |
| 英文名 | Lomitapide Mesylate |
| 别名 | 甲磺酸洛美他派 LOMITAPIDE甲磺酸盐 |
| 英文别名 | BMS 201038-04 AEGR733 Mesylate AEGR-733 Mesylate AEGR 733 Mesylate BMS201038 Mesylate BMS 201038 Mesylate LoMitapide Mesylate Lomitapide Mesylate BMS 201038 methanesulfonic acid salt 9H-Fluorene-9-carboxamide, N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]car bonyl]amino]-1-piperidinyl]butyl]-, methanesulfonate |
| CAS | 202914-84-9 |
| 化学式 | C40H41F6N3O5S |
| 分子量 | 789.8260592 |
| 溶解度 | 10毫米DMSO |
| 存储条件 | Inert atmosphere,Room Temperature |
| 靶点 | MTP |
| 参考资料 展开查看 | 1: Marbach JA, Thapa J, Goldenberg E, Duffy D. Pharmacogenetics in the Development of Lipid Lowering Medications: Lomitapide & Mipomersen in Clinical Practice. Del Med J. 2015 Aug;87(8):238-43. PubMed PMID: 26402926. 2: Roeters van Lennep J, Averna M, Alonso R. Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide. J Clin Lipidol. 2015 Jul-Aug;9(4):607-17. doi: 10.1016/j.jacl.2015.05.001. Epub 2015 May 14. PubMed PMID: 26228681. 3: Patel G, King A, Dutta S, Korb S, Wade JR, Foulds P, Sumeray M. Evaluation of the effects of the weak CYP3A inhibitors atorvastatin and ethinyl estradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects. J Clin Pharmacol. 2015 Jun 26. doi: 10.1002/jcph.581. [Epub ahead of print] PubMed PMID: 26120010. 4: Gouni-Berthold I, Berthold HK. Mipomersen and lomitapide: Two new drugs for the treatment of homozygous familial hypercholesterolemia. Atheroscler Suppl. 2015 May;18:28-34. doi: 10.1016/j.atherosclerosissup.2015.02.005. PubMed PMID: 25936301. 5: Stefanutti C, Blom DJ, Averna MR, Meagher EA, Theron Hd, Marais AD, Hegele RA, Sirtori CR, Shah PK, Gaudet D, Vigna GB, Sachais BS, Di Giacomo S, du Plessis AM, Bloedon LT, Balser J, Rader DJ, Cuchel M; Phase 3 HoFH Lomitapide Study Investigators. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial. Atheros |
Lomitapide Mesylate - 配置溶液浓度参考
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 1.266 ml | 6.331 ml | 12.661 ml |
| 5 mM | 0.253 ml | 1.266 ml | 2.532 ml |
| 10 mM | 0.127 ml | 0.633 ml | 1.266 ml |
| 5 mM | 0.025 ml | 0.127 ml | 0.253 ml |
最后更新：2024-01-02 23:10:35
供应商列表
主打产品现货供应
产品名: Lomitapide Mesylate 去供应商网站查看 询盘CAS: 202914-84-9
产地: 上海
规格: L872608
价格: 5mg-448,25mg-1197,100mg-3454,1ml-648
库存: 现货
电话: 13816333479/17821173903
手机: 13816333479/17821173903
电子邮件: wangrui@macklin.cn
QQ: 2885703204/288570320
微信: 19863730987/17821173903
产品名: Lomitapide (mesylate) 去供应商网站查看 询盘
CAS: 202914-84-9
产地: 上海
规格: 98%
价格: 5mg 700,10mg 1200,50mg 3000
电话: 18301782025
手机: 18301782025
电子邮件: 3008007403@qq.com
QQ: 3008007403
微信: 18301782025
产品描述: Lomitapide (mesylate) 98% MedMol 货号：S81427
CAS: 202914-84-9
产地: 上海
规格: 98%
价格: 5mg 700,10mg 1200,50mg 3000
电话: 18301782025
手机: 18301782025
电子邮件: 3008007403@qq.com
QQ: 3008007403
微信: 18301782025
产品描述: Lomitapide (mesylate) 98% MedMol 货号：S81427
主打产品现货供应
产品名: Lomitapide Mesylate 去供应商网站查看 询盘CAS: 202914-84-9
产地: 上海
规格: L872608
价格: 5mg-448,25mg-1197,100mg-3454,1ml-648
库存: 现货
电话: 13816333479/17821173903
手机: 13816333479/17821173903
电子邮件: wangrui@macklin.cn
QQ: 2885703204/288570320
微信: 19863730987/17821173903
产品名: Lomitapide (mesylate) 去供应商网站查看 询盘
CAS: 202914-84-9
产地: 上海
规格: 98%
价格: 5mg 700,10mg 1200,50mg 3000
电话: 18301782025
手机: 18301782025
电子邮件: 3008007403@qq.com
QQ: 3008007403
微信: 18301782025
产品描述: Lomitapide (mesylate) 98% MedMol 货号：S81427
CAS: 202914-84-9
产地: 上海
规格: 98%
价格: 5mg 700,10mg 1200,50mg 3000
电话: 18301782025
手机: 18301782025
电子邮件: 3008007403@qq.com
QQ: 3008007403
微信: 18301782025
产品描述: Lomitapide (mesylate) 98% MedMol 货号：S81427
您刚刚浏览过
你知道吗？
微信搜索化工百科或扫描下方二维码，添加化工百科小程序，随时随地查信息！